ArticleJournal of market access & health policy2024

Clinical Benefits of Sustained Oral Nirmatrelvir/Ritonavir Use for the Outpatient Treatment of COVID-19: Findings from the Taiwanese Health Authority Perspective Using a Decision Tree Modeling Approach.

Matthew Sussman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.